Empatica first to receive European CE mark for detecting early symptoms of COVID-19 using wearables MILAN, March 9, 2021 /PRNewswire/ -- Digital biomarker and medical device company Empatica is awarded CE-certification for its Aura system to detect and alert to respiratory infections, including COVID-19, early and before visible symptoms appear. Empatica received its CE mark as a Class lla medical device, meaning that Aura, as well as Empatica's remote health monitoring platform, Care, meet safety and performance requirements in Europe. This makes Aura the first product of its kind to receive CE-marking for respiratory infection detection using smart wearable technology. Aura's algorithm analyzes vital signs from Empatica's smartwatches, comparing data against historical baselines unique to each wearer. Requiring no manual input, when changes in a user's data suggest their body is beginning to fight an infection, Aura automatically displays a warning to Empatica's smartphone-based Care App, as well as to the cloud-based Care Portal, optionally informing their healthcare provider or caregivers. Through the Care Portal, healthcare professionals can simultaneously monitor the risk status of hundreds of individuals remotely, making Aura a powerful tool for maintaining healthy communities and preventing outbreaks.